Non-invasive assessment of atherosclerotic coronary lesion length using multidetector computed tomography angiography: comparison to quantitative coronary angiography by unknown
ORIGINAL PAPER
Non-invasive assessment of atherosclerotic coronary
lesion length using multidetector computed tomography
angiography: comparison to quantitative coronary
angiography
J. E. van Velzen • M. A. de Graaf • A. Ciarka • F. R. de Graaf • M. J. Schalij •
L. J. Kroft • A. de Roos • J. W. Jukema • J. H. C. Reiber • J. D. Schuijf •
J. J. Bax • E. E. van der Wall
Received: 1 September 2011 / Accepted: 4 January 2012 / Published online: 24 January 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Multidetector computed tomography angi-
ography (CTA) provides information on plaque extent
and stenosis in the coronary wall. More accurate lesion
assessment may be feasible with CTA as compared to
invasive coronary angiography (ICA). Accordingly,
lesion length assessment was compared between ICA
and CTA in patients referred for CTA who underwent
subsequent percutaneous coronary intervention (PCI).
89 patients clinically referred for CTA were subse-
quently referred for ICA and PCI. On CTA, lesion
length was measured from the proximal to the distal
shoulder of the plaque. Quantitative coronary angiog-
raphy (QCA) was performed to analyze lesion length.
Stent length was recorded for each lesion. In total, 119
lesions were retrospectively identified. Mean lesion
length on CTA was 21.4 ± 8.4 mm and on QCA
12.6 ± 6.1 mm. Mean stent length deployed was
17.4 ± 5.3 mm. Lesion length on CTA was signifi-
cantly longer than on QCA (difference 8.8 ± 6.7 mm,
P \ 0.001). Moreover, lesion length visualized on
CTA was also significantly longer than mean stent
length (CTA lesion length-stent length was 4.2 ±
8.7 mm, P \ 0.001). Lesion length assessed by CTA is
longer than that assessed by ICA. Possibly, CTA
provides more accurate lesion length assessment than
ICA and may facilitate improved guidance of percu-
taneous treatment of coronary lesions.
Keywords Coronary artery disease  Multidetector
computed tomography  Quantitative coronary
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Introduction
Invasive coronary angiography (ICA) has been tradi-
tionally used for evaluation of the presence and
severity of coronary artery disease (CAD). Accord-
ingly, the technique has been extensively utilized to
guide further treatment strategies, such as percutane-
ous coronary intervention (PCI) with stent placement.
In particular, the choice for stent length and diameter
is frequently decided on the basis of the 2-dimensional
ICA images. However, although ICA has an excellent
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ability to visualize the lumen and severity of luminal
narrowing, the presence of atherosclerotic plaque in
the arterial wall cannot be accurately visualized [1].
The chosen stent length may not always match the true
atherosclerotic plaque length and could potentially
lead to insufficient stent coverage of the plaque and
possible development of post-stent complications such
as arterial dissection, in-stent restenosis and stent
thrombosis [2–4].
Several studies comparing ICA to intravascular
ultrasound (IVUS) have shown that ICA indeed under-
estimates plaque extent [1, 5, 6]. Multidetector com-
puted tomography angiography (CTA) is increasingly
used to non-invasively evaluate the presence of CAD
[7, 8], and a growing number of patients referred for ICA
will have previously undergone non-invasive evaluation
by CTA. A particular strength of this modality is that it is
able to not only visualize luminal narrowing but also the
extent of atherosclerotic plaque in the arterial wall
[9, 10]. Accordingly, in patients with previous CTA,
who subsequently underwent ICA and PCI, lesion length
on CTA was compared to length on ICA.
Methods
Patients
A total of 89 patients were retrospectively analyzed, who
were clinically referred for CTA and had subsequent
ICA and PCI with stent implantation. For this retro-
spective evaluation, consecutive patients were selected
as part of an ongoing registry addressing the relative
merits of CTA in relation to other imaging techniques
[11]. All clinical data were retrieved from the depart-
mental Cardiology Information System (EPD-Vision,
Leiden University Medical Center). In each patient, the
presence of CAD risk factors such as diabetes, systemic
hypertension, hypercholesterolemia, positive family
history, smoking and obesity, were noted.
Multidetector computed tomography coronary
angiography
Data acquisition
Contra-indications for CTA were (1) (supra) ventric-
ular arrhythmias, (2) renal insufficiency (glomerular
filtration rate \ 30 ml/min), (3) known allergy to
iodine contrast material, (4) severe claustrophobia, (5)
pregnancy.
Patients received beta-blocking medication
(50–100 mg metoprolol orally, or 5–10 mg intrave-
nously) 1 h before CTA examination if the heart rate
was above 65 beats per minute, unless contra-
indicated. Forty-seven patients were scanned on a
64-detector row helical scanner (Aquilion 64, Toshiba
Medical Systems, Otawara, Japan). Scan parameters
were: 400 ms gantry rotation time, 100–135 kV tube
voltage and a tube current of 250–350 mA, depending
on body shape. Thirty-six patients were scanned on a
320-detector row volumetric scanner (Aquilion ONE,
Toshiba Medical Systems, Otawara, Japan). The heart
was imaged in a single heartbeat, using prospective
triggering with exposure interval depending on the
heart rate. Scan parameters were: 350 ms gantry
rotation time, 100–135 kV tube voltage and a tube
current of 400–580 mA, depending on body mass
index. In total, 60–90 ml contrast material (Iomeron
400, Bracco, Milan, Italy) was administered with a
rate of 5–6 ml/s followed by a saline flush. Subse-
quently, data sets were reconstructed in the best
available phase and transferred to a remote workstation.
CTA lesion length assessment
Post-processing of the CTA scans was performed on a
dedicated workstation (Vitrea FX 2.0.2, Vital images
Minnetonka, MN, USA). Coronary anatomy was
assessed in a standardized manner by dividing the
coronary artery tree into 17 segments according to the
modified American Heart Association classification.
CTA lesion length was evaluated in consensus by 2
experienced readers who were blinded to quantitative
coronary angiography (QCA) lesion length findings.
Firstly, the location of lesions was identified on ICA.
To match lesions identified on ICA with lesions on
CTA, landmarks such as coronary ostia, side-branches
and calcium deposits were used. A plaque on CTA was
defined as a structure C1 mm2 in the coronary artery
lumen [12]. Secondly, on CTA, lesion length was
determined on curved multiplanar reconstructions
(MPR’s) in two different angles for every lesion in
which PCI was performed. Lesion length (mm) was
measured on CTA from the proximal to distal shoulder
of the plaque with a dedicated Vitrea software display
tool (Vitrea FX 2.0.2, Minnetonka, MN, USA). A
tandem lesion within 4 mm of the edge of lesion was
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considered as part of the lesion. The average of these
two measurements was taken as the final CTA lesion
length. An example of lesion length measurement on
CTA is shown in Fig. 1. Radiation dose was quantified
with a dose-length product conversion factor of
0.014 mSv/(mGy cm) [13]. For the 320-row CTA,
patients with a low heart rate (\60 bpm) were scanned
full dose at 70–80% of R-R interval and estimated
mean radiation dose was 3.2 ± 1.1 mSv. Patients with
a higher heart rate (60–65 bpm) were scanned full
dose at 65–85% of R–R interval and estimated mean
radiation dose was 7.1 ± 1.7 mSv. For the 64-row
CTA, the estimated mean radiation dose was
18.1 ± 5.9 mSv, all performed with retrospective
gating.
Quantitative coronary angiography
Quantitative coronary angiography analysis was per-
formed by observer unaware of CTA findings with the
use of QCA-CMS version 6.0 (Medis, Leiden, The
Netherlands). Prior to measuring lesion length, images
were calibrated with use of the contrast filled catheter.
Subsequently, per lesion, the two best orthogonal
projections were chosen on which measurements were
performed to minimize foreshortening. Consequently,
lesion length (mm) was measured from the proximal
shoulder to the distal shoulder of the lesion. The
longest length measured on QCA was used for further
analysis. In addition, highest percent diameter stenosis
as measured by QCA was reported for each lesion. The
choice and size of stent used were left to the discretion
of operator. Per lesion, stent diameter and length were
reported. If more than one stent was planned, the total
stent length of all combined stents deployed was used.
Statistical analysis
Continuous variables were expressed as mean and
standard deviation, and categorical data were
expressed in numbers and percentages. Paired variables
were analyzed with Wilcoxon signed rank tests.
Statistical analysis was performed using SPSS software
(version 16.0, SPSS Inc., Chicago, IL, USA). A
P value \ 0.05 was considered statistically significant.
Results
Of the 89 patients, 4 were excluded in which the target
lesion length was not quantifiable on CTA. These
lesions were either a total chronic occlusion (n = 2) or
in-stent restenosis (n = 2). Furthermore 2 patients
were excluded due to impaired CTA image quality.
Consequently, 83 patients (59 males (71%), mean age
62 ± 10 years) and 119 lesions were included in the
Fig. 1 Example of atherosclerotic lesion length measurement
in two different views on multidetector computed tomography
angiography images with the use of a dedicated software tool. In
(a), a 3 dimensional volume rendered reconstruction of the heart
with the left anterior descending coronary artery (LAD) is
shown (arrow). In (b) lesion length measurement is performed
of a non-calcified lesion in the mid LAD. In this view, lesion
length measured was 16.6 mm. In (c), lesion length measure-
ment is performed of the same lesion, however in a different
angle. In this view, lesion length measured was 16.0 mm
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analysis. Baseline patient characteristics are described
in Table 1. The average time interval between CTA
and PCI was 63 ± 110 days. As determined by QCA,
the mean percent stenosis of the lesions was
71 ± 11%. Overall, lesions were most often located
in the left anterior descending coronary artery (56
lesions, 47%) followed by the left circumflex coronary
artery (35 lesions, 29%) and the right coronary artery
(28 lesions, 24%). Concerning plaque composition, 27
lesions (23%) were non-calcified, 72 lesions (60%)
were mixed and 20 lesions (17%) were calcified.
Lesion length
The mean lesion length measured on CTA was
21.4 ± 8.4 mm, as compared to a mean lesion length
on QCA of 12.5 ± 6.1 mm resulting in a mean
difference (CTA lesion length - QCA lesion length)
of 8.8 ± 6.7 mm. Only 2 lesions were longer on QCA
than on CTA, however the difference between these 2
lesions was only minor (13.2 mm on CTA vs.
14.3 mm on QCA and 5.7 mm on CTA vs. 6.7 mm
on QCA). Overall, mean CTA lesion length was
significantly longer than mean QCA lesion length
(P \ 0.001), as demonstrated in Fig. 2. At Bland–
Altman analysis, mean differences (±SD) of
8.8 ± 6.7 mm were observed between CTA and
ICA, with 95% limits of agreement ranging from
-4.3 to 22.0 (Fig. 3). The mean diameter of stents
deployed was 3.1 ± 0.3 mm, ranging from 3.0 to
4.0 mm. The length of stents deployed ranged from
8.0 to 33.0 mm (mean 17.5 ± 5.3 mm). Accordingly,
lesion length on CTA was also significantly longer
than mean stent length (CTA lesion length - stent
length was 4.2 ± 8.7 mm, P \ 0.001). Furthermore,
mean stent length exceeded lesion length on QCA;
stent length - QCA lesion length was 4.8 ± 6.2 mm
(P \ 0.001).
Table 1 Patient characteristics (n = 83)
n (%)
Age (mean ± SD) 62 ± 10
Gender (male/female) 59/24




Family history 37 (45%)
Smoking 33 (40%)
Previous stent (%) 18 (22%)
Complications during PCI
Edge dissection 6 (7%)
Stent thrombosisa 1 (1%)
BMI body mass index, PCI percutaneous coronary intervention
a Defined as definite, probable and possible stent thrombosis
within 1 month
Fig. 2 Box plot showing the difference between lesion length
assessment on multidetector computed tomography angiogra-
phy (CTA) and quantitative coronary angiography (QCA).
Lesion length assessment is less on QCA as compared to CTA
(P \ 0.001)
Fig. 3 Bland–Altman plot of lesion length (mm) shows the
difference between each pair plotted against the average value
of the same pair (solid line mean value of difference, dotted line
mean value of differences ± 2 SDs)
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Discussion
Comparison between ICA and non-invasive CTA
demonstrated that lesion length measured by CTA was
substantially longer than lesion length measured by
ICA. In addition, lesion length on CTA was compared
to the stent length selected for PCI. Interestingly,
lesion length measured by CTA significantly exceeded
the mean length over which the stent was deployed.
There are only very limited data regarding lesion
length measurement with CTA. Soon et al. [14]
compared atherosclerotic lesion length between ICA
and CTA (16-slice) in 30 patients and 44 lesions and
observed that lesion length was significantly longer on
CTA than on ICA with a median difference of 9.8 mm
(95% confidence interval of 7.3–13.3). Moreover, the
finding that ICA significantly underestimates athero-
sclerotic lesion length has also been demonstrated by
Yamagishi et al, who compared atherosclerotic lesion
length on ICA to grayscale IVUS, the current gold
standard for the evaluation of atherosclerosis [5]. The
authors demonstrated that lesion length on ICA (mean
lesion length of 12.4 ± 6.1 mm) was significantly
shorter than lesion length measured by IVUS (mean
lesion length of 16.3 ± 8.9 mm).
Although angiographically detected coronary ath-
erosclerosis has been linked to outcome in several
clinical trials [15–18], it has been suggested that ICA
considerably underestimates the overall extent of
CAD [19]. Indeed, when compared to IVUS, the
presence of angiographic disease did not reflect true
atherosclerotic plaque burden [1]. Mintz et al. [1]
compared the detection of atherosclerosis on ICA to
IVUS and found that only 7% of segments described
as normal on ICA were truly without any atheroscle-
rotic plaque on IVUS. Conversely, non-invasive CTA
has been shown to provide accurate evaluation of
coronary plaque burden [9, 20–22], with a good
correlation for detecting and characterizing athero-
sclerotic plaque in comparison to histology [23–25].
Moreover, Leber et al. [12] demonstrated a sensitivity
and specificity of 16-slice CTA for the detection of
coronary lesions as determined on IVUS of 85 and
92%, respectively. However, small plaques located in
distal segments were more difficult to evaluate,
particularly in CTA scans with reduced image quality
[12].
The large difference between ICA and CTA lesion
length assessment can be explained by the excellent
ability of CTA to visualize plaque and vessel remod-
elling in the arterial wall, in contrast to ICA. Indeed,
ICA only shows the contrast filled lumen and is unable
to visualize the arterial wall (with the exception of
large calcifications), and reference segments may not
be optimally evaluated by ICA [26]. Indeed, with
traditional invasive coronary angiography, lesions
with outward (positive) remodeling are frequently
underestimated or missed. Moreover, CTA is not
hampered by limitations of angiographic projection
such as foreshortening or difficulties in case of
tortuous vessels. However, it is of importance to
identify the presence of atherosclerosis even at sites
without significant luminal narrowing, and some acute
coronary syndromes may be triggered by sudden
disruption of atherosclerotic plaques that caused
neither significant luminal narrowing nor chest pain
complaints before the event [27]. It has been suggested
that the most rupture prone part of the plaque is not at
the maximum point of luminal narrowing but actually
located in the shoulders of the plaque [28]. Accord-
ingly, it is important to assess the entire plaque length.
It has also been demonstrated that insufficient
coverage of the target lesion increases the risk for
in-stent restenosis and stent thrombosis. Fujii et al.
retrospectively evaluated lesion characteristics using
IVUS leading to stent thrombosis after PCI [2]. The
authors observed that stent thrombosis occurred in
stents with significantly more residual plaque
upstream and downstream from the stent as compared
to lesions without stent thrombosis. Okabe et al. [3]
explored which IVUS related findings predicted the
risk for the development of stent thrombosis. The
authors observed that residual disease at the edge of
the stent was associated with subsequent stent throm-
bosis. Of note, a higher residual plaque burden
proximal from the stent has also been associated with
increased rates of in-stent restenosis [4]. Accordingly,
optimal assessment of the lesion length may improve
success and outcome of interventional procedures
[29].
Limitations
Several limitations need to be addressed. First, there
was a time-interval between CTA and PCI during
which atherosclerosis may have progressed. Second,
only lesions subsequently treated by PCI were
included in the study. Therefore, the current
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observations are only based on lesions with a high
grade stenosis. Third, in the current study QCA was
not part of the clinical routine of the laboratory and the
difference between the CTA lesion length and the stent
length chosen reflects the discrepancy between stent
length driven by visual assessment. Furthermore, the
attending interventional cardiologist did not incorpo-
rate lesion topography on CTA before performing
PCI. However, future studies should be performed to
evaluate the value and improved outcome of CTA
lesion assessment prior to PCI.
Conclusion
Lesion length assessed by CTA is longer than lesion
length assessed by ICA, which may facilitate improved
guidance of percutaneous treatment of coronary lesions.
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